BRD4-TARGETED THERAPY ABBV-744 CLINICAL DATA NO FURTHER A MYSTERY

Participant eaten grapefruit or grapefruit products and solutions within three days ahead of the first dose of study drug.- "Our study exposed the essential function of the KLF16/MYC regulatory axis in modulating tumor advancement and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, such as OTX015 or ABBV-744, wit